Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion type Assertion NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_head.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion evidence source_evidence_literature NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion SIO_000772 18676740 NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion wasDerivedFrom befree-20150227 NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.
- NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion wasGeneratedBy ECO_0000203 NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.